![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Wisløff F.
Publisher: Adis International
ISSN: 1170-7690
Source: PharmacoEconomics, Vol.16, Iss.4, 1999-10, pp. : 329-341
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pharmacoeconomic Considerations in the Treatment of Multiple Sclerosis
By Sharac Jessica McCrone Paul Sabes-Figuera Ramon
Drugs, Vol. 70, Iss. 13, 2010-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Drug Treatment of Overactive Bladder: Efficacy, Cost and Quality-of-Life Considerations
Drugs, Vol. 64, Iss. 15, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)